WebAug 10, 2024 · Following the close, GreenLight will have a pro forma enterprise value of approximately $1.2 billion based on the $10.00 per share price of ENVI common stock. WebMar 12, 2024 · Viela Bio Inc. is a clinical-stage biotechnology company. The Company is focused on developing treatments for severe inflammation and autoimmune diseases. Its product pipeline includes Inebilizumab, VIB4920 and VIB7734. Inebilizumab is a humanized mAb that binds to and depletes CD19+ B cells including plasmablasts and plasma cells.

HeartBeam, Inc. (BEAT) Stock Price, News, Quote & History - Yahoo Finance

WebMar 22, 2024 · Free-Float. 54,6%. More Financials. Company. GreenLight Biosciences Holdings, PBC, formerly Environmental Impact Acquisition Corp, is a biotechnology company. The Company is focused on Ribonucleic acid (RNA) research, design, and manufacturing for human, animal, and plant health. The Company has developed … WebSep 23, 2024 · About GreenLight Biosciences, Inc. Founded in 2008, GreenLight has raised approximately $235 million to date and is rapidly expanding to new market opportunities … su字体弯曲

Greenlight Biosciences Inc - Company Profile and News

WebGRNA Stock Price - GreenLight Biosciences Holdings PBC operates as a biotechnology company, which makes ribonucleic acid (RNA) products for human therapies and … WebAug 12, 2013 · Greenlight Biosciences is located in Medford, Massachusetts, United States. Who invested in Greenlight Biosciences? Greenlight Biosciences has 34 investors … WebGreenLight’s pipeline includes solutions to protect bees and stop fungal pathogens that often rot fruit like strawberries and grapes. We have a pipeline of 13 more products for human, plant, and animal health. su字体